NCT03130842View on ClinicalTrials.gov

Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

September 17, 2016

Primary Completion Date

February 15, 2017

Study Completion Date

February 15, 2017

Conditions
Diagnostic Esophagogastroduodenoscopy
Interventions
DRUG

Sublingual alprazolam

Patients receive one dose of oral formulation of alprazolam 0.5 mg for sublingual-administered at least 30 minutes before the procedure.

DRUG

Oral midazolam

Patients receive one dose of intravenous formulation of alprazolam 7.5 mg for oral-administered (in syrup with apple juice) at least 30 minutes before the procedure.

Trial Locations (1)

81746-73461

Department of Gastroenterology, Alzahra Hospital, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT03130842 - Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter